Gillies O'Bryan-Tear – Biography
Last update: March 29, 2026Executive profile
Gillies was Director at Clarity Pharmaceuticals, and Scientific Advisory Board at Fusion Pharmaceuticals. Gillies O'Bryan-Tear joined Oncoinvent in 2024.
Gillies O'Bryan-Tear is currentlyChairman of the Board at Oncoinvent - View - Oncoinvent org chart
Create your alert
to follow the career of Gillies O'Bryan-Tear.
Education
Gillies O'Bryan-Tear has a Bachelor in Medicine from University of Cambridge and a Master of Business Administration from Cranfield University - Cranfield School of Management.
They have also studied at University of Cambridge :
Find more alumni from University of Cambridge
They have also studied at Cranfield University - Cranfield School of Management :
Find more alumni from Cranfield University - Cranfield School of Management
More about Gillies O'Bryan-Tear
Selected links
Do you need to know more about Gillies O'Bryan-Tear? More results.
Participate
Social media
- Gillies O'Bryan-Tear on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Gillies O'Bryan-Tear
The colleagues of Gillies O'Bryan-Tear
Company Colleagues
- At Oncoinvent, Gillies O'Bryan-Tear has 18 colleagues including Oystein Soug (CEO), Hilde Steineger (Director)…
Industry Colleagues
- In the Healthcare industry, Gillies O'Bryan-Tear has 54,798 colleagues in 3,511 companies located in 59 countries. 39,527 executive movements have been recorded in the last 12 months. Learn more about Healthcare.
Report an error
Update the org chart details of Gillies O'Bryan-Tear.
Get in Touch
Here are a few tips for establishing great contacts.
